Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study

OBJECTIVE: To evaluate the efficacy and safety of Huashi Baidu Granules (HSBD) in treating patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. METHODS: A single-center retrospective cohort study was conducted during COVID-19 Omicron epidemic in the Mobile Cabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cai-yu, Zhang, Wen, Xu, Xiang-ru, Pu, Yu-ting, Tu, Ya-dan, Peng, Wei, Yao, Xuan, Zhou, Shuang, Fang, Bang-jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206345/
https://www.ncbi.nlm.nih.gov/pubmed/37222827
http://dx.doi.org/10.1007/s11655-023-3549-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206345/
https://www.ncbi.nlm.nih.gov/pubmed/37222827
http://dx.doi.org/10.1007/s11655-023-3549-8

Ejemplares similares